Will Non-COVID-19 Diagnostics Sales Drive Hologic's Q4 Earnings? [Yahoo! Finance]
Hologic, Inc. (HOLX)
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.hologic.com
Company Research
Source: Yahoo! Finance
Panther utilization in its Molecular Diagnostics franchise. Higher gantry deliveries and robust service revenues are likely to have contributed to the Breast Health segment's performance. Furthermore, MyoSure is likely to have emerged as the key driver of the GYN Surgical division's revenues. We anticipate that the company's fiscal 2024 fourth-quarter financial results, slated to be released on Nov. 4 after the closing bell, will reflect these aspects. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar In the meantime, click here to see if the stock could be a good bet before earnings. Diagnostics Quarter after quarter, the core Molecular Diagnostics business has been leading the way for Hologic's Diagnostics segment. The company holds a competitive advantage with Panther due to its efficient workflow, automation, ease of use and continuously expanding menu on the platform. In the fourth quarter of fiscal 2024, the number of Panther placements is expect
Show less
Read more
Impact Snapshot
Event Time:
HOLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HOLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
News
- FDA Roundup: October 29, 2024 [Yahoo! Finance]Yahoo! Finance
- Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.MarketBeat
- Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women's Health [Yahoo! Finance]Yahoo! Finance
- Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s HealthBusiness Wire
- Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)? [Yahoo! Finance]Yahoo! Finance
HOLX
Earnings
- 7/29/24 - Beat
HOLX
Sec Filings
- 10/4/24 - Form 3
- 9/13/24 - Form 8-K
- 9/3/24 - Form 4
- HOLX's page on the SEC website